男性不妊症とアンドロゲン受容体遺伝子のトリヌクレオチド繰り返しの拡張との関連
A T Dowsing1, E L Yong, M Clark
1Institute of Reproduction and Development and Department of Mathematics and Statistics, Monash University, Monash Medical Centre, Victoria, Australia.
Lancet (London, England)
|August 31, 1999
まとめ
アンドロゲン受容体遺伝子の拡張CAGトリヌクレオチドリピートが男性不妊症と関連している. この発見は,欠陥性精子生成と男性不妊の潜在的遺伝性の遺伝的リスク要因を示唆しています.
科学分野:
- 遺伝学 遺伝学とは
- 生殖生物学 生殖生物学
- 分子生物学は分子生物学である.
背景:
- アンドロゲンとアンドロゲン受容体は精子生成に不可欠です.
- アンドロゲン受容体遺伝子の変異は,男性の生育力を損なう可能性があります.
- この研究は,男性不妊症におけるトリヌクレオチドの繰り返し拡大の役割を調査しています.
研究 の 目的:
- アンドロゲン受容体遺伝子のトリヌクレオチド重複拡張が男性不妊症と関連しているかどうかを判断する.
- CAGの繰り返し長さと精子発生性障害との関係を分析する.
主な方法:
- 67人の男性不妊患者と対照群におけるアンドロゲン受容体遺伝子の分析.
- PCR,単一鎖形状ポリモルフィズム,DNAシーケンシングを使用した.
- トリヌクレオチド (CAG) 繰り返し長さおよび点変異の評価.
主要な成果:
- アンドロゲン受容体遺伝子の点変異は見つかりませんでした.
- 異症性アゾオスペルミアまたはオリゴゾオスペルミアの不妊患者は,対照群よりもCAGの繰り返し経路が有意に長かった.
- 長いCAGの繰り返しの長さは,精子発生性障害のリスクが高いことと関連していました.
結論:
- アンドロゲン受容体遺伝子のCAG繰り返しの長さと欠陥性精子発生との間には相関関係がある.
- イントラサイトプラズマ精子注射によるこの変異の遺伝は,将来の男性不妊を増加させる可能性があります.
- さらに繰り返される延長は,不妊症の重度の増加と神経変性疾患のリスクをもたらす.
関連する概念動画
01:19X-linked Traits
In most mammalian species, females have two X sex chromosomes and males have an X and Y. As a result, mutations on the X chromosome in females may be masked by the presence of a normal allele on the second X. In contrast, a mutation on the X chromosome in males more often causes observable biological defects, as there is no normal X to compensate. Trait variations arising from mutations on the X chromosome are called “X-linked”.
02:32X and Y Chromosomes
Among mammals, the gender of an organism is determined by the sex chromosomes. Humans have two sex chromosomes, X and Y. Every human diploid cell has 22 pairs of autosomes and one pair of sex chromosomes. A human female has two X chromosomes, while a male has one X chromosome and one Y chromosome.
The germline cells such as egg and sperm cells carry only half the number of chromosomes, i.e., 22 autosomes and one sex chromosome. All eggs have an X chromosome, while sperm cells can carry an X or...
The germline cells such as egg and sperm cells carry only half the number of chromosomes, i.e., 22 autosomes and one sex chromosome. All eggs have an X chromosome, while sperm cells can carry an X or...
02:19The Y Chromosome Determines Maleness
The Y chromosome is a sex chromosome found in several vertebrates and mammals, including humans. In addition to 22 pairs of autosomes, the human males have one X chromosome and one Y chromosome. In these organisms, the presence or absence of the Y chromosome determines the development of male traits.
Evolution
Around 300 million years ago, the two sex chromosomes diverged from two identical autosomal chromosomes. Over time, the Y chromosome has lost most of its genes, shrinking in size. Today,...
Evolution
Around 300 million years ago, the two sex chromosomes diverged from two identical autosomal chromosomes. Over time, the Y chromosome has lost most of its genes, shrinking in size. Today,...
02:32Exon Recombination
The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes.
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Exon shuffling follows “splice frame rules.” Each exon has three reading...
01:23Infertility in Males
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...